Status:
COMPLETED
Manuka Honey Eye Drops VS Conventional Treatment of Meibomian Gland Dysfunction Related Dry Eye Disease
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Meibomian Gland Dysfunction
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Assessor-masked (Single blind, randomized controlled trial comparing the conventional treatment group to an interventional group using 16% Manuka Honey topical eye drops.
Detailed Description
Purpose To evaluate the effects of conventional treatment compared to use of Manuka Honey eye drops in the treatment of meibomian gland dysfunction related dry eye disease. Design Assessor-masked (Si...
Eligibility Criteria
Inclusion
- meibomian gland dysfunction stage 2-4
Exclusion
- \<18 years old Unable to consent Recent ophthalmic surgery \<6m Abnormalities of lid position Allergy to honey/bee products Contact lens wearers Patients on long term topical medications apart from lubricants
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04457648
Start Date
June 1 2018
End Date
June 1 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
chinese university of Hong kong
Hong Kong, China